lamotrigine has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arpin, S | 1 |
| Lagrue, E | 1 |
| Bodard, S | 1 |
| Chalon, S | 1 |
| Castelnau, P | 1 |
| Jones-Humble, SA | 1 |
| Morgan, PF | 1 |
| Cooper, BR | 1 |
2 other studies available for lamotrigine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study.
Topics: Animals; Anticonvulsants; Autoradiography; Basal Ganglia; Basal Ganglia Diseases; Dopamine Plasma Me | 2009 |
The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; | 1994 |